YTHDC2 recognized m6A-modified miR-17-5p and promoted its degradation, resulting in increased expression of its downstream tumor suppressor gene Mitofusin 2 (MFN2), leading to decreased mitochondrial fusion and increased sensitivity to 5-FU in CRC [56]. The gene discussed is MFN2; the disease is colorectal carcinoma.